457 related articles for article (PubMed ID: 15534200)
1. Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors.
Kwon J; Lee SR; Yang KS; Ahn Y; Kim YJ; Stadtman ER; Rhee SG
Proc Natl Acad Sci U S A; 2004 Nov; 101(47):16419-24. PubMed ID: 15534200
[TBL] [Abstract][Full Text] [Related]
2. Intracellular messenger function of hydrogen peroxide and its regulation by peroxiredoxins.
Rhee SG; Kang SW; Jeong W; Chang TS; Yang KS; Woo HA
Curr Opin Cell Biol; 2005 Apr; 17(2):183-9. PubMed ID: 15780595
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial H2O2 regulates the angiogenic phenotype via PTEN oxidation.
Connor KM; Subbaram S; Regan KJ; Nelson KK; Mazurkiewicz JE; Bartholomew PJ; Aplin AE; Tai YT; Aguirre-Ghiso J; Flores SC; Melendez JA
J Biol Chem; 2005 Apr; 280(17):16916-24. PubMed ID: 15701646
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of platelet-derived growth factor receptor by the tumor suppressor PTEN provides a novel mechanism of action of the phosphatase.
Mahimainathan L; Choudhury GG
J Biol Chem; 2004 Apr; 279(15):15258-68. PubMed ID: 14718524
[TBL] [Abstract][Full Text] [Related]
5. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate.
Maehama T; Dixon JE
J Biol Chem; 1998 May; 273(22):13375-8. PubMed ID: 9593664
[TBL] [Abstract][Full Text] [Related]
6. Redox regulation of PI 3-kinase signalling via inactivation of PTEN.
Leslie NR; Bennett D; Lindsay YE; Stewart H; Gray A; Downes CP
EMBO J; 2003 Oct; 22(20):5501-10. PubMed ID: 14532122
[TBL] [Abstract][Full Text] [Related]
7. Bisperoxovanadium compounds are potent PTEN inhibitors.
Schmid AC; Byrne RD; Vilar R; Woscholski R
FEBS Lett; 2004 May; 566(1-3):35-8. PubMed ID: 15147864
[TBL] [Abstract][Full Text] [Related]
8. PTEN permits acute increases in D3-phosphoinositide levels following TCR stimulation but inhibits distal signaling events by reducing the basal activity of Akt.
Seminario MC; Precht P; Bunnell SC; Warren SE; Morris CM; Taub D; Wange RL
Eur J Immunol; 2004 Nov; 34(11):3165-75. PubMed ID: 15468057
[TBL] [Abstract][Full Text] [Related]
9. Regulation of phosphoinositide metabolism, Akt phosphorylation, and glucose transport by PTEN (phosphatase and tensin homolog deleted on chromosome 10) in 3T3-L1 adipocytes.
Ono H; Katagiri H; Funaki M; Anai M; Inukai K; Fukushima Y; Sakoda H; Ogihara T; Onishi Y; Fujishiro M; Kikuchi M; Oka Y; Asano T
Mol Endocrinol; 2001 Aug; 15(8):1411-22. PubMed ID: 11463863
[TBL] [Abstract][Full Text] [Related]
10. Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors.
Bianco R; Shin I; Ritter CA; Yakes FM; Basso A; Rosen N; Tsurutani J; Dennis PA; Mills GB; Arteaga CL
Oncogene; 2003 May; 22(18):2812-22. PubMed ID: 12743604
[TBL] [Abstract][Full Text] [Related]
11. Induction of Akt phosphorylation in rat primary astrocytes by H2O2 occurs upstream of phosphatidylinositol 3-kinase: no evidence for oxidative inhibition of PTEN.
Salsman S; Felts N; Pye QN; Floyd RA; Hensley K
Arch Biochem Biophys; 2001 Feb; 386(2):275-80. PubMed ID: 11368352
[TBL] [Abstract][Full Text] [Related]
12. Dual role of SRC homology domain 2-containing inositol phosphatase 2 in the regulation of platelet-derived growth factor and insulin-like growth factor I signaling in rat vascular smooth muscle cells.
Sasaoka T; Kikuchi K; Wada T; Sato A; Hori H; Murakami S; Fukui K; Ishihara H; Aota R; Kimura I; Kobayashi M
Endocrinology; 2003 Sep; 144(9):4204-14. PubMed ID: 12933696
[TBL] [Abstract][Full Text] [Related]
13. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics.
Zhong H; Chiles K; Feldser D; Laughner E; Hanrahan C; Georgescu MM; Simons JW; Semenza GL
Cancer Res; 2000 Mar; 60(6):1541-5. PubMed ID: 10749120
[TBL] [Abstract][Full Text] [Related]
14. PTEN as an effector in the signaling of antimigratory G protein-coupled receptor.
Sanchez T; Thangada S; Wu MT; Kontos CD; Wu D; Wu H; Hla T
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4312-7. PubMed ID: 15764699
[TBL] [Abstract][Full Text] [Related]
15. The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells.
Asano T; Yao Y; Zhu J; Li D; Abbruzzese JL; Reddy SA
Oncogene; 2004 Nov; 23(53):8571-80. PubMed ID: 15467756
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity of protein tyrosine phosphatase activity to the redox environment, cytochrome C, and microperoxidase.
Salsman SJ; Hensley K; Floyd RA
Antioxid Redox Signal; 2005; 7(7-8):1078-88. PubMed ID: 15998263
[TBL] [Abstract][Full Text] [Related]
17. Phosphatidylinositol 3,4,5-trisphosphate modulation in SHIP2-deficient mouse embryonic fibroblasts.
Blero D; Zhang J; Pesesse X; Payrastre B; Dumont JE; Schurmans S; Erneux C
FEBS J; 2005 May; 272(10):2512-22. PubMed ID: 15885100
[TBL] [Abstract][Full Text] [Related]
18. Preferential killing of PTEN-null myelomas by PI3K inhibitors through Akt pathway.
Zhang J; Choi Y; Mavromatis B; Lichtenstein A; Li W
Oncogene; 2003 Sep; 22(40):6289-95. PubMed ID: 13679867
[TBL] [Abstract][Full Text] [Related]
19. Living with lethal PIP3 levels: viability of flies lacking PTEN restored by a PH domain mutation in Akt/PKB.
Stocker H; Andjelkovic M; Oldham S; Laffargue M; Wymann MP; Hemmings BA; Hafen E
Science; 2002 Mar; 295(5562):2088-91. PubMed ID: 11872800
[TBL] [Abstract][Full Text] [Related]
20. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]